Biotech startups that raised a seed round in New York City
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| heXem bio | New York | Seed | $10.4M | 2026-09-15 |
| ElectroKare | New York | Seed | $4.0M | 2026-07-01 |
| Kimba | New York | Seed | $5.4M | 2026-06-16 |
| Century Health | New York | Seed | $5.0M | 2026-05-19 |
| OncoPrecision | New York | Seed | $4.5M | 2025-11-24 |
| Helex | New York | Seed | $3.5M | 2025-10-30 |
| Argon AI | New York | Seed | $5.5M | 2025-07-02 |
| EvolutionaryScale | New York | Seed | $142.0M | 2024-06-25 |
8 rows of the CSV in 5 of its 18 columns.
- The 121 biotech startups in New York City whose last round is a seed round have raised $640.6M in total.
- 19 of them closed their most recent round in the last 12 months, $158.3M combined.
- The largest of those rounds is Proxima's $86.3M seed round, dated January 2026.
- The most recent is Nephrogen's $20K seed round on 6 October 2026.
- SOSV SF & NY (Fka IndieBio) is an investor in 6 of them, more than any other fund.
- Health care is the most common other sector, with 87 companies (72%).
- 48% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 1 to 10 employees (61% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
11 of 121| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| heXem bio | HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells and extend healthy lifespan. | Biotech | Seed | $10.4M | 2026-09-15 | $10.4M | SOSV, SOSV SF & NY (Fka IndieBio) | 1 to 10 | 2024 |
| ElectroKare | ElectroKare builds computational models that simulate human physiological systems and processes. | Artificial intelligence | Seed | $4.0M | 2026-07-01 | $4.0M | iVenture Accelerator, Techstars Physical Health, Fort Worth, Texas | 11 to 50 | 2025 |
| Kimba | Kimba uses AI to analyze biometric data and deliver personalized scent treatments for better sleep and health. | Artificial intelligence | Seed | $5.4M | 2026-06-16 | $6.4M | Techstars | 1 to 10 | 2024 |
| Century Health | Century Health applies AI to real-world clinical data to accelerate drug development and commercialization. | Artificial intelligence | Seed | $5.0M | 2026-05-19 | $7.0M | Alumni Ventures, Everywhere Ventures, 2048 Ventures +1 | 1 to 10 | 2023 |
| OncoPrecision | OncoPrecision develops patient-centric therapeutic antibodies. | Biotech | Seed | $4.5M | 2025-11-24 | $11.1M | SOSV, SOSV SF & NY (Fka IndieBio), GRID EXPONENTIAL +2 | 11 to 50 | 2020 |
| Helex | Helex works on making gene editing safer. | Biotech | Seed | $3.5M | 2025-10-30 | $4.6M | SOSV, SOSV SF & NY (Fka IndieBio) | 11 to 50 | 2021 |
| Argon AI | Argon AI automates life sciences activities in clinical and commercial settings. | Artificial intelligence | Seed | $5.5M | 2025-07-02 | $11.5M | Y Combinator, Pioneer Fund, Eight Capital | 1 to 10 | 2023 |
| EvolutionaryScale | EvolutionaryScale develops biological AI models for therapeutic design. | Artificial intelligence | Seed | $142.0M | 2024-06-25 | $142.0M | Lux Capital, NVentures | 11 to 50 | 2023 |
| Native AI | Native AI provides an always-on market intelligence platform for understanding customers and creating better experiences. | Artificial intelligence | Seed | $3.5M | 2023-04-06 | $5.7M | Capital Innovators, Connetic Ventures, IvyCap Ventures +2 | 11 to 50 | 2018 |
| Flextrapower | Flextrapower is a remote-monitoring company powered by graphene technology. | Biotech | Seed | $120K | 2019-07-15 | $1.2M | Techstars, MassChallenge, National Science Foundation +2 | 11 to 50 | 2015 |
| Zpoken AI | Zpoken AI is a data science company focused on cognitive solutions. | Artificial intelligence | Seed | $130K | 2017-02-01 | $130K | Starta VC, Starta Accelerator | 11 to 50 | 2016 |
Table 1. Biotech startups that raised a seed round in New York City: the 11 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 121.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | heXem bio | HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells and extend healthy lifespan. | Biotech | Seed | $10.4M | 2026-09-15 | $10.4M | SOSV, SOSV SF & NY (Fka IndieBio) | 1 to 10 | 2024 |
| 2 | Kimba | Kimba uses AI to analyze biometric data and deliver personalized scent treatments for better sleep and health. | Artificial intelligence | Seed | $5.4M | 2026-06-16 | $6.4M | Techstars | 1 to 10 | 2024 |
| 3 | Century Health | Century Health applies AI to real-world clinical data to accelerate drug development and commercialization. | Artificial intelligence | Seed | $5.0M | 2026-05-19 | $7.0M | Alumni Ventures, Everywhere Ventures, 2048 Ventures +1 | 1 to 10 | 2023 |
| 4 | OncoPrecision | OncoPrecision develops patient-centric therapeutic antibodies. | Biotech | Seed | $4.5M | 2025-11-24 | $11.1M | SOSV, SOSV SF & NY (Fka IndieBio), GRID EXPONENTIAL +2 | 11 to 50 | 2020 |
| 5 | ElectroKare | ElectroKare builds computational models that simulate human physiological systems and processes. | Artificial intelligence | Seed | $4.0M | 2026-07-01 | $4.0M | iVenture Accelerator, Techstars Physical Health, Fort Worth, Texas | 11 to 50 | 2025 |
Table 2. Biotech startups that raised a seed round in New York City: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | SOSV SF & NY (Fka IndieBio) | Venture capital firm | San Francisco, United States | 6 | 5% | 2 | heXem bio, OncoPrecision |
| 2 | SOSV | Venture capital firm | Princeton, United States | 6 | 5% | 2 | heXem bio, OncoPrecision |
| 3 | Techstars | Startup accelerator | New York, United States | 2 | 2% | 1 | Kimba |
| 4 | Alumni Ventures | Angel group | Manchester, United States | 2 | 2% | 1 | Century Health |
| 5 | Pioneer Fund | Startup accelerator | Toronto, Canada | 2 | 2% | ||
| 6 | Techstars Physical Health, Fort Worth, Texas | Startup accelerator | Boulder, United States | 1 | 1% | 1 | ElectroKare |
| 7 | iVenture Accelerator | Startup accelerator | Urbana, United States | 1 | 1% | 1 | ElectroKare |
| 8 | Everywhere Ventures | Venture capital firm | New York, United States | 1 | 1% | 1 | Century Health |
| 9 | LifeX Ventures | Venture capital firm | New York, United States | 1 | 1% | 1 | Century Health |
| 10 | 2048 Ventures | Venture capital firm | New York, United States | 1 | 1% | 1 | Century Health |
| 11 | Underdog Labs | Venture capital firm | San Francisco, United States | 1 | 1% | 1 | Synaptrix Labs |
| 12 | Creative Ventures | Venture capital firm | Oakland, United States | 1 | 1% | 1 | OncoPrecision |
| 13 | AIR Capital | Venture capital firm | Buenos Aires, Argentina | 1 | 1% | 1 | OncoPrecision |
| 14 | GRID EXPONENTIAL | Startup accelerator | Buenos Aires, Argentina | 1 | 1% | 1 | OncoPrecision |
| 15 | Eight Capital | Venture capital firm | Mumbai, India | 1 | 1% |
Table 3. Biotech startups that raised a seed round in New York City: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 87 | 72% | $559.4M |
| Software | 33 | 27% | $351.0M |
| Artificial intelligence | 27 | 22% | $344.6M |
| Hardware | 6 | 5% | $16.5M |
| Fintech | 3 | 2% | $14.2M |
| Education | 3 | 2% | $78.4M |
| Cybersecurity | 2 | 2% | $13.2M |
| Energy | 1 | 1% | $6.5M |
Table 4. Biotech startups that raised a seed round in New York City by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 121 | 100% | $2.3M |
Table 5. Biotech startups that raised a seed round in New York City by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 5% | $20K |
| September 2026 | 3 | 16% | $37.5M |
| August 2026 | 1 | 5% | |
| July 2026 | 2 | 11% | $5.5M |
| June 2026 | 1 | 5% | $5.4M |
| May 2026 | 1 | 5% | $5.0M |
| April 2026 | 1 | 5% | |
| January 2026 | 3 | 16% | $97.3M |
| December 2025 | 3 | 16% | $3.2M |
| November 2025 | 3 | 16% | $4.5M |
Table 6. Biotech startups that raised a seed round in New York City: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 13 | 11% | $150.6M |
| 2025 | 24 | 20% | $100.1M |
| 2024 | 12 | 10% | $153.6M |
| 2023 | 14 | 12% | $22.9M |
| 2022 | 13 | 11% | $17.8M |
| 2021 | 10 | 8% | $30.5M |
Table 7. Biotech startups that raised a seed round in New York City by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 28 | 25% |
| 2020 to 2022 | 27 | 24% |
| 2015 to 2019 | 46 | 40% |
| 2010 to 2014 | 8 | 7% |
| Before 2010 | 5 | 4% |
Table 8. Biotech startups that raised a seed round in New York City by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 72 | 61% |
| 11 to 50 | 45 | 38% |
| 51 to 100 | 1 | 1% |
| 251 to 500 | 1 | 1% |
Table 9. Biotech startups that raised a seed round in New York City by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is a seed round and its headquarters is in New York City. On 16 November 2026 that is 121 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 11 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 121 rows: 54 have no round amount, 0 no city and 23 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in New York City whose last round is a seed round are on the list?
- 121, in the file dated 16 November 2026. 19 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 121 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.